We also studied the S100A4 as an inhibitor—it blocking the interface of the V domain and S100A1 [51] to stop the cell proliferation [52] and could be used as the treatment of cancer [53] and RAGE related disease [54–57]. The gene discussed is S100A1; the disease is cancer.